Sponsor or institution
Clinical trials and research at Fondazione Oncotech
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Fondazione Oncotech that are recruiting, in Italy. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Tucatinib with trastuzumab and capecitabine for HER2‑positive metastatic breast cancer in routine care
This project will see if tucatinib combined with trastuzumab and capecitabine works and is safe for people with HER2‑positive metastatic breast cancer who have had at least two prior anti‑HER2 treatments.
-
Neoadjuvant treatment for early breast cancer using abemaciclib and giredestrant
This study is testing if a combination of two medications can help postmenopausal women with early-stage breast cancer before they have surgery.
Quick answers
How many clinical trials run by Fondazione Oncotech are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Italy. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.